Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-000246·OnKure Therapeutics, Inc.
Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Common Stock · CUSIP: 68277Q105
Event date: 2024-12-31
- Filing-level shares
- 706,733
- Percent of class
- 5.58%
- The Vanguard Group
Shares: 706,733 · Class: 5.58%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000246
- Form type
- SCHEDULE 13G
- Filer
- OnKure Therapeutics, Inc.
- CIK
- CIK 1637715
- Filed
- Jan 31, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership